>
RTA Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret AS logo

RTALB - RTA Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret AS Share Price

TRY22.06 -0.2  -1.1%

Last Trade - 12/05/21

Sector
Healthcare
Size
Small Cap
Market Cap £76.0m
Enterprise Value £77.9m
Revenue £19.4m
Position in Universe 252nd / 649
Bullish
Bearish
Unlock RTALB Revenue
Momentum
Relative Strength (%)
1m -31.9%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -65.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
33.7 31.8 38.5 20.5 16.8 230.4 +46.9%
+104.1 -45.7 -0.6 +15.8 -12.4 +1,247
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, RTALaboratuvarlari Biyoljik UI v MST AS revenues increasedfrom TRY16.8M to TRY230.4M. Net income increased fromTRY4.4M to TRY60.9M. Revenues reflect an increase in demandfor the Company's products and services due to favorablemarket conditions. Net income benefited from EquityEarnings - before Tax increase from TRY2.6M to TRY31.5M(income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for RTALB
Graphical History

Revenue

RTALB Revenue Unlock RTALB Revenue

Net Income

RTALB Net Income Unlock RTALB Revenue

Normalised EPS

RTALB Normalised EPS Unlock RTALB Revenue

PE Ratio Range

RTALB PE Ratio Range Unlock RTALB Revenue

Dividend Yield Range

RTALB Dividend Yield Range Unlock RTALB Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
RTALB EPS Forecasts Unlock RTALB Revenue
Profile Summary

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS is a Turkey-based company engaged in the research, development and production of in vitro diagnostics. Its diagnostic products include: Clinical Microbiology, such as chromogenic media, culture media in petri dishes, tubes and bottles, rodac petri surcheck, and tuberculosis diagnosis products; ELISA Kits, such as HBsAg ELISA Kit; Molecular Diagnostics, such as nucleic acid isolation kits, real-time PCR instruments, real-time PCR kits and RTA VOLTRAN voral detection system, as well as other tests. Its Research includes: dehydrated culture media, such as dehydrated chromogenic culture media; nucleic acid isolation kits and real-time PCR.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated May 13, 1996
Public Since June 2, 2014
No. of Shareholders: n/a
No. of Employees: 52
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Istanbul Stock Exchange
Shares in Issue 41,000,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
41400
View larger map
+
Address , KOCAELI, 41400, Turkey
Web http://www.rtalabs.com.tr
Phone +90 262 6485300
Contact ()
Auditors Ata Uluslararasi Denetim ve Serbet Muhasebeci Mali Musavirli
RTALB Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for RTALB
Upcoming Events for RTALB
Frequently Asked Questions for RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
What is the RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS share price?

As of 12/05/21, shares in RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS are trading at TRY22.06, giving the company a market capitalisation of £76.0m. This share price information is delayed by 15 minutes.

How has the RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS share price performed this year?

Shares in RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS are currently trading at TRY22.06 and the price has moved by -49.29% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS price has moved by -61.35% over the past year.

What are the analyst and broker recommendations for RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS?

There are no analysts currently covering RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS.

When will RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS next release its financial results?

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS dividend yield?

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS does not currently pay a dividend.

Does RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS pay a dividend?

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS does not currently pay a dividend.

When does RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS next pay dividends?

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS does not currently pay a dividend.

How do I buy RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS shares?

To buy shares in RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS?

Shares in RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS are currently trading at TRY22.06, giving the company a market capitalisation of £76.0m.

Where are RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS shares listed? Where are RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS shares listed?

Here are the trading details for RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS:

Country of listing: Turkey
Exchange: IST
Ticker Symbol: RTALB
What kind of share is RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS?

Based on an overall assessment of its quality, value and momentum, RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS share price forecast 2021?

We were not able to load any forecast data for RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS.

How can I tell whether the RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS. Over the past six months, the relative strength of its shares against the market has been -53.29%. At the current price of TRY22.06, shares in RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS are trading at -40.05% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS PE Ratio?

The RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS PE ratio based on its reported earnings over the past 12 months is 10.12. The shares are currently trading at TRY22.06.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS?

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS's management team is headed by:

Resat Ultav - CHM
Ali Tas - VCH
M. Tayyip Turkaslan - DRC
Tahsin Yesildere - DRC
Gokhan Celikelli - DRC
Bilgen Yusufoglu - DGM
Arzu Gunaydin - DSL
Sinan Levent - DSL
Ahmet Baris - DSL
Alev Kahraman - OTH
Bahadir Akdemir - VRD
Guven Akat - FID
Who are the major shareholders of RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS?

Here are the top five shareholders of RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS based on the size of their shareholding:

ICG Finansal Danismanlik AS Corporation
Percentage owned: 17.59% (7.21m shares)
Guler Yatirim Holding AS Corporation
Percentage owned: 8.41% (3.45m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 0.13% (54.5k shares)
SPDR Portfolio Emerging Markets ETF Mutual Fund
Percentage owned: 0.08% (33.8k shares)
SPDR S&P Emerging Markets Small Cap ETF Mutual Fund
Percentage owned: 0.05% (20.8k shares)
Similar to RTALB
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.